Target Trial Emulation and Bias Through Missing Eligibility Data: An Application to a Study of Palivizumab for the Prevention of Hospitalization due to Infant Respiratory Illness. (2022)
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: TBD
Parent Publication: American Journal of Epidemiology
Issue: TBD